168 related articles for article (PubMed ID: 32596152)
1. Activation of STING by cGAMP Regulates MDSCs to Suppress Tumor Metastasis
Cheng H; Xu Q; Lu X; Yuan H; Li T; Zhang Y; Tan X
Front Oncol; 2020; 10():896. PubMed ID: 32596152
[TBL] [Abstract][Full Text] [Related]
2. Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway.
Lu X; Wang X; Cheng H; Wang X; Liu C; Tan X
Ann Med; 2023 Dec; 55(1):2210845. PubMed ID: 37162544
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect.
Lu X; Cheng H; Xu Q; Tan X
Cancer Biother Radiopharm; 2023 Oct; 38(8):543-557. PubMed ID: 33719535
[No Abstract] [Full Text] [Related]
4. A sequential scheme including PTT and 2'3'-cGAMP/CQ-LP reveals the antitumor immune function of PTT through the type I interferon pathway.
Song X; Wang M; Liu S; Liu H; Jiang A; Zou Y; Deng Y; Qin Q; Song Y; Zheng Y
Pharmacol Res; 2023 Oct; 196():106939. PubMed ID: 37758101
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Ohkuri T; Kosaka A; Ishibashi K; Kumai T; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2017 Jun; 66(6):705-716. PubMed ID: 28243692
[TBL] [Abstract][Full Text] [Related]
6. AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model.
Goswami A; Deb B; Goyal S; Gosavi A; Mali M; Martis AM; Khurana P; Gangar M; Raykar D; Mohanty A; Kulkarni A
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235254
[TBL] [Abstract][Full Text] [Related]
7. ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity.
Wang L; Cao L; Li Z; Shao Z; Chen X; Huang Z; He X; Zheng J; Liu L; Jia XM; Xiao H
J Immunol; 2024 Jun; ():. PubMed ID: 38847616
[TBL] [Abstract][Full Text] [Related]
8. cGAMP inhibits tumor growth in colorectal cancer metastasis through the STING/STAT3 axis in a zebrafish xenograft model.
Jiang X; Liu G; Hu Z; Chen G; Chen J; Lv Z
Fish Shellfish Immunol; 2019 Dec; 95():220-226. PubMed ID: 31586458
[TBL] [Abstract][Full Text] [Related]
9. CXCR2
Zhu H; Gu Y; Xue Y; Yuan M; Cao X; Liu Q
Oncotarget; 2017 Dec; 8(70):114554-114567. PubMed ID: 29383101
[TBL] [Abstract][Full Text] [Related]
10. COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.
Li ZL; Ye SB; OuYang LY; Zhang H; Chen YS; He J; Chen QY; Qian CN; Zhang XS; Cui J; Zeng YX; Li J
Oncoimmunology; 2015 Nov; 4(11):e1044712. PubMed ID: 26451317
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8
Kosaka A; Yajima Y; Yasuda S; Komatsuda H; Nagato T; Oikawa K; Kobayashi H; Ohkuri T
Int J Cancer; 2023 Apr; 152(8):1685-1697. PubMed ID: 36495276
[TBL] [Abstract][Full Text] [Related]
13. Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts.
Maenhout SK; Van Lint S; Emeagi PU; Thielemans K; Aerts JL
Int J Cancer; 2014 Mar; 134(5):1077-90. PubMed ID: 23983191
[TBL] [Abstract][Full Text] [Related]
14. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
Lim HX; Choi S; Cho D; Kim TS
Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
[TBL] [Abstract][Full Text] [Related]
15. An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway.
Bose D; Su Y; Marcus A; Raulet DH; Hammond MC
Cell Chem Biol; 2016 Dec; 23(12):1539-1549. PubMed ID: 27889408
[TBL] [Abstract][Full Text] [Related]
16. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
Fortin C; Yang Y; Huang X
Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells Contribute to Susceptibility to
Onyilagha C; Kuriakose S; Ikeogu N; Jia P; Uzonna J
J Immunol; 2018 Jul; 201(2):507-515. PubMed ID: 29898961
[TBL] [Abstract][Full Text] [Related]
18. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
[TBL] [Abstract][Full Text] [Related]
19. STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Sibal PA; Matsumura S; Ichinose T; Bustos-Villalobos I; Morimoto D; Eissa IR; Abdelmoneim M; Aboalela MAM; Mukoyama N; Tanaka M; Naoe Y; Kasuya H
Mol Oncol; 2024 May; 18(5):1259-1277. PubMed ID: 38400597
[TBL] [Abstract][Full Text] [Related]
20. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
